In this issue of JAIDS, Verdery and colleagues report a social network study of persons who inject drugs (PWID) in 2 cities in the Philippines.
As the world approaches the midway point between the 2014 launch of the 90–90–90 targets and their December 2020 deadline, UNAIDS has reviewed the progress made. This has been done with the support of national AIDS programmes, which report data annually to the United Nations and the guidance of national programme managers, researchers and other experts within the UNAIDS Scientific and Technical Advisory Committee (STAC) on 90–90–90.
DPNSEE initiative for 2017 is creation of a glossary of terms related to the problem of drugs that we hope
will contribute to better understanding the drug problem in more empathic manner.
This is the International Network of People who Use Drugs’ (INPUD) Consensus Statement on Drug Use Under Prohibition. It was launched in Kuala Lumpur in 2015 and focuses on human rights, health, and the law in relation to people who use drugs.
The 2017 report comes at a time when the international community has acted decisively to achieve consensus on a way forward for joint action.
The purpose of this Technical Brief is to assist Global Fund applicants in their efforts to include and expand programs to remove human rights and gender-related barriers to HIV prevention, diagnosis and treatment services. This Brief discusses the barriers these programs help to remove, the various forms the programs take, the need to cost and allocate budget for them, and how to implement them in effective ways and at appropriate scale. It also aims to help stakeholders ensure that, as they are rolled out, HIV health services and programs promote and protect human rights and gender equality.
The report focuses on hepatitis B and C, which are responsible for 96% of all hepatitis mortality. It presents data along the five strategic directions (strategic information, interventions, equity, financing and innovation) – key pillars of the GHSS to facilitate monitoring of progress in countries, regions and globally, and to measure the impact of interventions on reducing new infections and
saving lives between 2015 and 2030.
The tool describes how services can be designed and implemented to be accessible and acceptable to people who inject drugs. This requires respectful and ongoing engagement, and this publication gives particular attention to programmes run in close partnership with, or by, organizations of people who use drugs.
HCV prevalence in Asia and the Pacific varies between countries. HCV infection is due to unsterile medical injections (2 , 3) contaminated blood transfusions, (4) traditional cultural practices60 and, more recently, injecting drug use. (5) While iatrogenic transmission still occurs in some countries, transmission as the result of injecting drug use is increasing. (6)
Services to reduce drug-related harms are failing to keep up with growing need, despite pledges to combat AIDS among people who inject drugs.
This site is supported by grant from Robert Carr Network Fund (RCNF).
- About Us
- Contact Us
- Our Programs
- Join Campaigns
- Become a member
- Submit an Event
- Stop Duterte Now Video Messages
- Robert Carr Civil Society Network Fund (RCNF) project
- Making the Global Fund fit for purpose
- Women who Use Drugs Study
- Harm Reduction Advocacy in Asia
- Organizational System Strengthening